Leerink Partnrs Analysts Lower Earnings Estimates for PRVA

Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) - Stock analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for Privia Health Group in a research report issued to clients and investors on Thursday, February 27th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.07 per share for the quarter, down from their previous estimate of $0.08. The consensus estimate for Privia Health Group's current full-year earnings is $0.14 per share. Leerink Partnrs also issued estimates for Privia Health Group's Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.09 EPS, FY2025 earnings at $0.33 EPS, Q1 2026 earnings at $0.10 EPS, Q2 2026 earnings at $0.11 EPS, Q3 2026 earnings at $0.12 EPS, Q4 2026 earnings at $0.13 EPS and FY2027 earnings at $0.61 EPS.

Other research analysts have also recently issued reports about the stock. Piper Sandler boosted their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a report on Friday, February 28th. Needham & Company LLC boosted their price objective on shares of Privia Health Group from $25.00 to $30.00 and gave the company a "buy" rating in a report on Friday, February 28th. Macquarie assumed coverage on shares of Privia Health Group in a report on Monday, December 16th. They set an "outperform" rating and a $25.00 price objective for the company. Canaccord Genuity Group boosted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a report on Friday, February 28th. Finally, JMP Securities reissued a "market outperform" rating and set a $26.00 price objective on shares of Privia Health Group in a report on Friday, February 14th. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $26.47.

Remove Ads

Privia Health Group Stock Down 1.7 %

Privia Health Group stock traded down $0.43 during trading hours on Monday, hitting $25.26. The stock had a trading volume of 794,983 shares, compared to its average volume of 751,382. The stock has a market capitalization of $3.04 billion, a P/E ratio of 252.63, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $26.04. The stock's 50-day moving average price is $22.83 and its 200-day moving average price is $20.75.

Institutional Investors Weigh In On Privia Health Group

Hedge funds have recently bought and sold shares of the business. Nordea Investment Management AB raised its stake in Privia Health Group by 33.1% during the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company's stock valued at $6,953,000 after purchasing an additional 86,910 shares in the last quarter. Victory Capital Management Inc. raised its stake in Privia Health Group by 402.9% during the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company's stock valued at $3,260,000 after purchasing an additional 143,446 shares in the last quarter. Franklin Resources Inc. raised its stake in Privia Health Group by 2.2% during the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after purchasing an additional 28,480 shares in the last quarter. Barclays PLC raised its stake in Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after purchasing an additional 158,188 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in Privia Health Group by 8.4% during the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company's stock valued at $3,430,000 after purchasing an additional 14,641 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.